{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-176628","form_type":"8-K","ticker":"LITS","cik":"0001262104","company_name":"Lite Strategy, Inc.","filed_at":"2023-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.219420+00:00","generated_at":"2026-06-13T15:26:31.675228+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MEI Pharma Board Rejects Anson/Cable Car Unsolicited Bid, Reaffirms Infinity Merger","bullets":["Board unanimously rejects unsolicited, non-binding proposal from Anson Advisors and Cable Car Capital as undervaluing the Company.","Proposal was at a significant discount to MEI's cash position; Board sees no basis for discussions on an alternative transaction.","Board reaffirms recommendation for pending merger with Infinity; combined pipeline of three clinical-stage programs.","Key clinical data from combined pipeline expected in 6-24 months, including from two programs by year-end."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-176628","json":"https://secwatch.observer/filing/0001193125-23-176628.json","markdown":"https://secwatch.observer/filing/0001193125-23-176628.md","text":"https://secwatch.observer/filing/0001193125-23-176628.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1262104/000119312523176628/0001193125-23-176628-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1262104/000119312523176628/d526740d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:26:31.675228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}